期刊文献+

PLAU基因近端启动子区变异与阿尔茨海默病的关系 被引量:1

Association between the promoter polymorphisms of PLAU gene and Alzheimer’s disease
暂未订购
导出
摘要 目的研究尿激酶型纤溶酶原激活剂(urokinase-type plasminogen activator gene,PLAU)基因近端启动子区变异与散发性阿尔茨海默病发病的相关性。方法根据NINCDS-ADRDA年标准收集98例AD患者,以101例正常人作为对照。采用聚合酶链反应-限制性片段长度多态性(polymerase chain reaction-restriction fragment length polymorphism,PCR-RFLP)结合直接测序的方法,筛查PLAU基因启动子区多态性位点,并对所有受试者进行PLAU启动子区多态位点分型,采用病例-对照相关性研究方法 ,研究其与AD发病的关系。用SPSS11.5统计软件包进行等位基因和基因型分布的比较及它们与疾病的关联分析。结果中国人群中的PLAU近端启动子区存在两个多态性位点-25C/T(rs2227579)和43G/T(rs2227580)。-25C/C基因型增加了AD发病风险(校正后OR=1.671,95%CI:1.098~2.577,P=0.018),43G/G基因型增加了AD发病风险(校正后OR=1.773,95%CI:1.156~2.732,P=0.009)。PLAU基因启动子区-25C/T位点与43G/T位点未发现存在连锁不平衡(D’=0.031,r2=0.000)。结论 PLAU基因启动子区变异与阿尔茨海默病的发生有相关性。 Objective The purpose of this study was to determine whether Alzheimer’s disease (AD) is associated with the promoter polymorphisms of urokinase-type plasminogen activator gene (PLAU). Methods Our study was carried out in 98 AD patients (according to NINCDS-ADRDA) and 101 control subjects from North China. We used a combination of polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing technique to screen the promoter region of the PLAU gene. Results In Chinese Han populations,we found two polymorphisms in PLAU promoter:-25C/T (rs2227579) and 43G/T (rs2227580). Logistic analyses indicated that compared with C/T and T/T genotypes,-25C/C genotype increased 1.7-fold risk for developing AD (adjusted OR=1.681,95%CI:1.098~2.577,P=0.017),while 43G/G genotype increased 1.8-fold risk for AD (adjusted OR=1.776,95%CI:1.156~2.732,P=0.009) compared with G/T and T/T genotype. Linkage disequilibrium analysis was conducted and no association between the two sites was found (D’=0.031,r2=0.000). Conclusion The present study provides evidence that PLAU promoter polymorphisms are associated with development of AD.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2010年第7期621-624,共4页 Journal of Apoplexy and Nervous Diseases
关键词 阿尔茨海默病 尿激酶型纤溶酶原激活剂基因 启动子 单核苷酸多态性 PLAU gene Promoter Alzheimer’s disease Polymorphism
  • 相关文献

参考文献3

二级参考文献16

  • 1Lewontin R. On measures of gametic disequilibrium. Genetics 1988; 120:849-52.
  • 2Chen WY, Shi YY, Zheng YL, et al. Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum Mol Genet 2004; 13:2991-5.
  • 3Shi Y, Zhao X, Yu L, et al. Genetic structure adds power to detect schizophrenia susceptibility at SLIT3 in the Chinese Han population. Genome Res 2004; 14:1345-9.
  • 4Zhao X, Shi Y, Tang J, et al. A case control and family based association study of the neuregulinl gene and schizophrenia. J Med Genet 2004; 41:31-4.
  • 5Guo S, Shi Y, Zhao X, et al. No genetic association between polymorphisms in the AMPA receptor subunit GluR4 gene (GRIA4) and schizophrenia in the Chinese population. Neurosci Lett 2004; 369:168-72.
  • 6Yang MS, Yu L, Guo TW, et al. Evidence for association between single nucleotide polymorphisms in T complex protein 1 gene and schizophrenia in the Chinese Han population. J Med Genet 2004; 41:e63.
  • 7Morelli L, Llovera L, Ibendahl S, et al. The degradation of amyloid beta as a therapeutic strategy in Alzheimer' s disease and cerebrovascular amyloidoses[ J]. Neurochem Res,2002,27 ( 11 ) : 1387-1399.
  • 8Tucker HM, Kihiko M, Caldwell JN, et al. The plasmin system is induced by and degrades amyloid-beta aggregates [ J ]. J Neurosci, 2000,20( 11 ) :3937-3946.
  • 9Ledesma MD, Da Silva JS, Crassaerts K, et al. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer' s disease brains[ J]. EMBO Rep,2000,1 (6) :530-535.
  • 10Li X,Bokman AM,Linas M,et al. Solution structure of the kringle domain from urokinase-type plasminogen activator [ J ]. J Mol Biol, 1994,235 ( 5 ) : 1548-1559.

共引文献393

同被引文献56

  • 1Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease [ J 1. Acta Neuropatho1,2009 ; 118 ( 1 ) :5-36.
  • 2Raux G,Guyant-Mar6chal L,Martin C,et al. Molecular diagnosis of auto- somal dominant early onset Alzheimer's disease:an update [ J3. J Med Genet,2005 ;42(10) :793-5.
  • 3Bertram L. Alzheimer's disease genetics current status and future perspec- tives [ J 1- Int Rev Neurobio1,2009 ;84 : 167-84.
  • 4Figgins JA, Minster RL, Demirci FY, et al. Association studies of 22 can- didate SNPs with late-onset Alzheimer's disease(J]. J Am J Med Genet B Neuropsychiatr Genet,2009;150B(4) :520-6.
  • 5Coon KD, Myers A J, Craig DW,et al. A high-density whole-genome asso- ciation study reveals that APOE is the major susceptibility gene for spo- radic late-onset Alzheimer' s disease ( J 1- J CIin Psychiatry, 2007 ;68 ( 4 ) : 613-8.
  • 6Bertram L,Tanzi RE. Genome-wide association studies in Alzheimer's dis- ease[J). Hum Mol Genet,2009;18(R2) :R137-45.
  • 7Xuemin Xu. Garmma-secretase catalyzes sequential cleavages of the AI3PP transmembrane domain [ J). J Alzheimers Dis ,2009 ; 16 ( 2 ) :211-24.
  • 8Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hy- pothesis : a genetic perspective [ J 1. Ce11,2005 ; 120 (4) :545-55.
  • 9Rovelet-Lecrux A, Hannequin D, Raux G, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy(J). Nat Genet,2006 ;38( 1 ) :24-6.
  • 10Basan H, Bogdanovic N, Ingelsson M ,et al. Clinical and neuropathologi- cal features of the arctic APP gene mutation causing early-onset Alzhei- mer disease[ J. Arch Neurol,2008;65(4) :499-505.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部